Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat the untreatable, today announced that together with Western ...
Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a ...
Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /CNW/ - Specific Biologics Inc. ("Specific"), a ...
Abstract: Diabetes is a chronic condition that affects how the body processes blood sugar, leading to consistently high blood glucose levels. Predicting diabetes early can go a long way in reducing ...
This study develops a machine-learning-based approach to retrieve significant wave height (SWH) from soil moisture active passive (SMAP) radiometer data under tropical cyclone (TC) conditions, ...
In the study “Human-AI Synergy in Statistical Arbitrage: Enhancing Robustness Across Volatile Financial Markets,” published in the journal Risks, the researcher investigates how combining AI with ...
In most boardrooms, the final decision still comes down to a small circle of leaders weighing a narrow set of choices. Yet the problems they face now contain thousands, sometimes millions, of possible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results